Sheba Launches New Pilot Program to Help Those with Severe Allergies get Safely Vaccinated

200 Israelis with severe allergies were vaccinated for the first time at Sheba as part of a critical pilot program. Individuals with severe allergies are otherwise currently turned away from health clinics due to concerns of severe reactions to the COVID-19 vaccine. If successful, the hospital will share its findings with other medical centers and health funds, potentially expanding the program to the public. Prof. Nancy Agmon-Levin, head of the Clinical Immunology, Angioedema and Allergy Unit, Lupus and Autoimmune Diseases Clinic at Sheba, recently discussed this program with the Jerusalem Post.